| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/07/2010 | WO2010000794A1 Plants having enhanced yield-related traits and a method for making the same by overexpressing a polynucleotide encoding a tfl1-like protein |
| 01/07/2010 | WO2010000758A1 Method for optimizing proteins having the folding pattern of immunoglobulin |
| 01/07/2010 | WO2010000741A1 Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders |
| 01/07/2010 | WO2010000675A1 Polypeptides, cyclic polypeptides and pharmaceutical compositions comprising thereof for inhibiting activity of trkb |
| 01/07/2010 | WO2010000485A1 Msp-1 protein preparations from plasmodium |
| 01/07/2010 | WO2010000374A1 Protein complexes and screening methods |
| 01/07/2010 | WO2010000269A1 Transconjugants of lactic acid bacteria |
| 01/07/2010 | WO2010000061A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness |
| 01/07/2010 | WO2010000041A1 Anti- p2x7 peptides and epitopes |
| 01/07/2010 | WO2010000012A1 Method for preventing transport of a neurotropic virus |
| 01/07/2010 | WO2009140382A3 Treatment of hearing and balance impairments using compounds having erythropoietin activity |
| 01/07/2010 | WO2009138250A3 Identification of ligand recognition domains |
| 01/07/2010 | WO2009133529A3 Processes for refolding of insulin |
| 01/07/2010 | WO2009126858A3 Materials and methods for improved immunoglycoproteins |
| 01/07/2010 | WO2009124258A3 Novel protein for binding bacillus thuringiensis cry toxins and fragments of cadherins for enhancing cry toxicity against dipterans |
| 01/07/2010 | WO2009124168A3 Variants of nrr activate plant disease resistance |
| 01/07/2010 | WO2009108364A3 Antagonistic analogues of ghrh |
| 01/07/2010 | WO2009100255A3 Modified leptin polypeptides and their uses |
| 01/07/2010 | WO2009083808A3 Compositions and methods for treating erectile dysfunction |
| 01/07/2010 | WO2009069123A3 Compositions comprising fibrous polypeptides and polysaccharides |
| 01/07/2010 | WO2009063072A3 Pharmaceutical compositions comprising glp-1 peptides or exendin-4 and a basal insulin peptide |
| 01/07/2010 | WO2009039414A3 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 01/07/2010 | WO2009013461A8 Growth hormone fusion proteins |
| 01/07/2010 | WO2009003977A8 Plants having enhanced yield-related traits and a method for making the same |
| 01/07/2010 | WO2000055325A9 Plant centromeres |
| 01/07/2010 | US20100005548 Nucleic Acid Sequences and Methods of Use for the Production of Plants with Modified Polyunsaturated Fatty Acids |
| 01/07/2010 | US20100005543 Toxin genes and methods for their use |
| 01/07/2010 | US20100004871 Identities, specificities, and use of twenty two (22) differentially expressed protein biomarkers for blood based diagnosis of breast cancer |
| 01/07/2010 | US20100004433 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 01/07/2010 | US20100004430 Peptide-based immunization therapy for treatment of atherosclerosis |
| 01/07/2010 | US20100004428 Method of Preparing Propionic Acid-Terminated Polymers |
| 01/07/2010 | US20100004321 Recombinant Staphylococcal Phage Lysin as an Antibacterial Agent |
| 01/07/2010 | US20100004316 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 01/07/2010 | US20100004178 Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction |
| 01/07/2010 | US20100004177 Toxin complex proteins and genes from xenorhabdus bovienii |
| 01/07/2010 | US20100004176 Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
| 01/07/2010 | US20100004175 Novel bmp-12-related proteins and methods of their manufacture |
| 01/07/2010 | US20100004169 CCN3 peptide |
| 01/07/2010 | US20100004167 Csf3r polypeptides and uses thereof |
| 01/07/2010 | US20100004165 Novel Protein Transduction Domains and Uses Therefor |
| 01/07/2010 | US20100004164 Platelet aggregation inhibitor composition |
| 01/07/2010 | US20100004162 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof |
| 01/07/2010 | US20100003747 Cultured xenopus laevis cell lines expressing mutant adenomatous polyposis coli gene |
| 01/07/2010 | US20100003721 Human interferon-beta mutein |
| 01/07/2010 | US20100003719 Trimerising Module |
| 01/07/2010 | US20100003716 Isoprene synthase variants for improved microbial production of isoprene |
| 01/07/2010 | US20100003712 Biomarker for assessing response to chymase treatment |
| 01/07/2010 | US20100003706 Syphilis diagnostic tests and kits |
| 01/07/2010 | US20100003694 Biomarkers and Uses Thereof |
| 01/07/2010 | US20100003685 Polynucleotide |
| 01/07/2010 | US20100003682 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
| 01/07/2010 | US20100003673 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
| 01/07/2010 | US20100003394 Protein gel formation |
| 01/07/2010 | US20100003336 Vesicles of self-assembling block copolymers and methods for making and using the same |
| 01/07/2010 | US20100003283 Lipid a deficient mutants of neisseria meningitidis |
| 01/07/2010 | US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening |
| 01/07/2010 | US20100003273 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/07/2010 | US20100003269 Methods and uses of cauliflower and collard for recombinant protein production |
| 01/07/2010 | US20100003267 Anti-angiogenic compounds |
| 01/07/2010 | US20100003262 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 01/07/2010 | US20100003251 Uses of IL-23 Agonists and Antagonists; Related Reagents |
| 01/07/2010 | US20100003240 Cancer treatment with endothelin receptor antagonists |
| 01/07/2010 | US20100003234 Cellulase activity; used to make bioethanol, in food and textile treatment, in waste treatment; breaks down lignocellulose |
| 01/07/2010 | US20100003233 Compositions and methods for treatment of microbial infections |
| 01/07/2010 | US20100003195 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 01/07/2010 | US20100003194 Inhibitor screening method and atopic dermatitis like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte and utilization of same |
| 01/07/2010 | CA2734567A1 Insulin fusion polypeptides |
| 01/07/2010 | CA2729868A1 Anti- p2x7 peptides and epitopes |
| 01/07/2010 | CA2729818A1 Vaccines comprising pasteurella multocida recombinant filamentous hemagglutinin peptides |
| 01/07/2010 | CA2729810A1 Tgf-.beta. antagonist multi-target binding proteins |
| 01/07/2010 | CA2729793A1 Msp-1 protein preparations from plasmodium |
| 01/07/2010 | CA2729749A1 Tnf-a antagonist multi-target binding proteins |
| 01/07/2010 | CA2729734A1 Differentiation of pluripotent stem cells |
| 01/07/2010 | CA2729591A1 Method for optimizing proteins having the folding pattern of immunoglobulin |
| 01/07/2010 | CA2729496A1 Promoters from brassica napus for seed specific gene expression |
| 01/07/2010 | CA2729414A1 Vaccine against amyloid folding intermediate |
| 01/07/2010 | CA2728926A1 Plants having enhanced yield-related traits and a method for making the same by overexpressing a polynucleotide encoding a tfl1-like protein |
| 01/07/2010 | CA2728622A1 Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
| 01/07/2010 | CA2727646A1 Protein complexes and screening methods |
| 01/06/2010 | EP2141243A2 Protein scaffolds for antibody mimics and other binding proteins |
| 01/06/2010 | EP2141235A1 Adiponectin receptor and gene coding for the same |
| 01/06/2010 | EP2141230A1 Fluorescent labeled fused protein for assaying adenosine triphosphate |
| 01/06/2010 | EP2141228A1 Method for the generation of proliferating and differentiating B cell lines |
| 01/06/2010 | EP2141227A2 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 01/06/2010 | EP2141179A1 A fluorescence based reporter construct for the direct detection of TGF-beta receptor activation and modulators thereof |
| 01/06/2010 | EP2141178A1 Method of producing antithrombin composition |
| 01/06/2010 | EP2141177A1 MSP-1 protein preparations from Plasmodium |
| 01/06/2010 | EP2141176A1 New bacteriophage adhesion proteins |
| 01/06/2010 | EP2140879A1 Composition and method for treating cancer using herpes virus |
| 01/06/2010 | EP2140876A1 Therapeutic agent comprising vasohibin |
| 01/06/2010 | EP2140875A1 Compositions and methods for healthy pregnancy |
| 01/06/2010 | EP2140247A1 Method for modulating activity of t lymphocytes |
| 01/06/2010 | EP2140019A1 A method for detecting the binding between mdm2 and the proteasome |
| 01/06/2010 | EP2140015A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
| 01/06/2010 | EP2140008A2 Yeast expression systems |
| 01/06/2010 | EP2140005A1 Antagonists of ligands and uses thereof |
| 01/06/2010 | EP2139997A1 Asparaginase enzyme variants and uses thereof |
| 01/06/2010 | EP2139991A1 Targeted neuronal and glial human embryonic stem cell line |
| 01/06/2010 | EP2139917A2 Anti-androgen peptides and uses thereof in cancer therapy |